J. Haaning

发表

Phase I, randomized, double‐blind, placebo‐controlled, single‐dose escalation study of the recombinant factor VIIa variant BAY 86‐6150 in hemophilia

M. Laffan, J. Mahlangu, J. Windyga, 2012, Journal of thrombosis and haemostasis : JTH.

Preclinical pharmacokinetics and biodistribution of subcutaneously administered glycoPEGylated recombinant factor VIII (N8‐GP) and development of a human pharmacokinetic prediction model

K. Almholt, M. Loftager, M. Kreilgaard, 2018, Journal of thrombosis and haemostasis : JTH.

Complete cDNA sequence of the preproform of human pregnancy-associated plasma protein-A. Evidence for expression in the brain and induction by cAMP.

M. Overgaard, C. Oxvig, P. Ebbesen, 1996, European journal of biochemistry.

Advances in Hemophilia Care: Report of Two Symposia at the Hemophilia 2010 World Congress

E. Steinhagen-Thiessen, C. Hermans, G. Dolan, 2012, Advances in Therapy.

Risk Mitigation Strategy for Concizumab Clinical Trials after Pause Due to Non-Fatal Thrombotic Events

Trine Høyer Rose, S. Seremetis, S. Tamer, 2020 .

Phase I, Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Study of the rFVIIa Variant (BAY 86–6150) In Hemophilia A or B with or without Inhibitors.

M. Laffan, J. Mahlangu, J. Windyga, 2010 .

Development of a tail vein transection bleeding model in fully anaesthetized haemophilia A mice – characterization of two novel FVIII molecules

P. Johansen, M. Tranholm, J. Haaning, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Expression of Recombinant Human Pregnancy-associated Plasma Protein-A and Identification of the Proform of Eosinophil Major Basic Protein as Its Physiological Inhibitor*

C. Conover, M. Overgaard, M. Christiansen, 2000, The Journal of Biological Chemistry.

Messenger ribonucleic acid levels of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein: expression in human reproductive and nonreproductive tissues.

C. Conover, M. Overgaard, M. Christiansen, 1999, Biology of reproduction.

Identification of Angiotensinogen and Complement C3dg as Novel Proteins Binding the Proform of Eosinophil Major Basic Protein in Human Pregnancy Serum and Plasma (*)

C. Oxvig, G. Gleich, T. Stigbrand, 1995, The Journal of Biological Chemistry.

BAY 94–9027, a PEGylated Recombinant Human FVIII, Shows Less Immunogenicity Compared to Un-PEGylated Recombinant FVIII

I. Ivens, J. Haaning, R. Zierz, 2010 .

Expression of recombinant murine pregnancy-associated plasma protein-A (PAPP-A) and a novel variant (PAPP-Ai) with differential proteolytic activity.

L. Giudice, C. Conover, M. Overgaard, 2002, European journal of biochemistry.

Location and nature of carbohydrate groups in proform of human major basic protein isolated from pregnancy serum.

P. Højrup, C. Oxvig, L. Sottrup-jensen, 1994, Biochemistry and molecular biology international.